Navigation Links
Pharmagen Announces Year-End Financial Results
Date:4/1/2013

SILVER SPRING, Md., April 1, 2013 /PRNewswire/ -- Pharmagen, Inc. (OTCBB: PHRX) (the "Company" or "Pharmagen") today announced financial results for the fiscal year ended December 31, 2012. On a consolidated basis, net revenues for the fiscal year 2012 totaled $4.26 mln vs. 2011 of $863K, representing 490% growth year-over-year. The company had one-time, non-recurring expenses of $1.2 mln related to going public and the investments it made in building a foundation for future growth. The company spent much of 2012 building the cornerstones for a move toward profitability in 2013. This included acquiring BryceRx Laboratories, Inc., which not only grew the company's topline with prescription based revenue but also dramatically increased the company's gross profit.

Pharmagen's branded OTC product, Clotamin™, has demonstrated consistent momentum growing from being carried in several hundred stores to being carried nationally at over 7,000 locations at one of the leading pharmacy chains in the world. The company has made significant investments in Clotamin and expects continued growth of the product across other major national retailers and internationally.

From a brand prospective, the company went through a strategic realignment. Pharmagen is now moving toward being the leader in pragmatic solutions to the drug shortage crisis in the United States. With a multifaceted approach, the company is meeting the demands of the health provider market through dynamic, independent wholesale, compounding/admix, and innovative IT solutions. The company grew its Pharmagen Distribution pharmaceutical wholesale license base to 47 states and continues to rapidly grow Pharmagen Laboratories license base as well. The company made significant investment across the board from IT, accounting, equipment and personnel.

Pharmagen brought on a Chief Financial Officer from a major hospital system, '/>"/>

SOURCE Pharmagen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)...  Lannett Company, Inc. (NYSE: LCI ) today ... Genuity 35th Annual Growth Conference on Wednesday, August 12, ... Hotel.  A webcast of the presentation ... encouraged to visit the web site at least 10 ... register, download and install any necessary software.  The presentation ...
(Date:7/30/2015)... 30, 2015  Cleave Biosciences today announced that ... granted the company a key patent providing the ... CB-5083. This newly issued patent, "Fused ... U.S. 9,062,026, allows for claims on the composition ... oral inhibitor of p97, a critical enzyme that ...
(Date:7/30/2015)... , July 30, 2015 Flexpoint Ford, a ... services sectors, today announced that it has entered into ... Bryan Stuart to form Kastle Therapeutics, LLC (Kastle).  ... , will focus on acquiring, developing and commercializing pharmaceuticals ... acquisition opportunities include select therapies already approved for marketing, ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
(Date:7/30/2015)... , ... July 30, 2015 , ... ... program at ATA’s 21st Annual Meeting and Tradeshow focused exclusively on telemedicine, telehealth ... 300 cutting-edge health care technology vendors, will take place May 14-17, 2016 in ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At ... and San Bernardino counties, today announced that Dr. Michael Demoratz, PhD, LCSW, CCM ... is a strong proponent of early access to palliative care services for the ...
(Date:7/30/2015)... TX (PRWEB) , ... July 30, 2015 , ... ... Grant Program and fourth annual Institute Scholar Program. In partnership with Patient Experience ... of patient experience, develop leaders on the front lines and throughout the experience ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Mesothelioma ... Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The bill was introduced in Congress ... King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston ... the annual All-Stars Summit. Google Partners is the platform for search marketing agencies ... full support and tools necessary to run successful search marketing campaigns. Google Partners ...
Breaking Medicine News(10 mins):Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2
... ... Times, hundreds of people taking the type-2 diabetes drug Avandia® suffer heart attacks and ... Law firm. , ... (PRWEB) February 26, 2010 -- Maher Law Firm attorneys are investigating possible Avandia® ...
... , ... ... ... ...
... the pain and suffering experienced by women being treated for ... Buffalo School of Social Work professor. , The randomized trial ... constant pain among 124 women with metastatic breast cancer, according ... Social Work, a faculty member in the Buffalo Center for ...
... Study found they showed lower brain activity when on ... News) -- Reduced brain activity may explain why drivers ... report. , They used functional MRI to monitor brain ... using a driving simulator. When they were learning the ...
... , ... eve of its twelfth anniversary Connecticut Governor M. Jodi Rell honored Mountainside Addiction Treatment ... the state. , ... Canaan, CT (PRWEB) February 26, 2010 -- On the eve of its twelfth ...
... mussels, clams and can cause paralysis, scientists say , ... tide" this spring and summer could threaten the New ... Maine Toxicity project. , An abundant cyst population in ... bloom of the toxic algae Alexandrium fundyense . ...
Cached Medicine News:Health News:Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia 2Health News:Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia 3Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 2Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 3Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 4Health News:Hypnosis can help control pain among women with metastatic breast cancer, UB Researcher finds 2Health News:Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut 2Health News:Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut 3Health News:Predicted 'Red Tide' Could Make Shellfish a Dangerous Dish 2
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
... Pro Resectoscope is based on the award ... enables the surgeon to perform TURis - ... working element, HF cable and electrodes, Olympus ... resection in saline, supporting both, standard TUR ...
... internal drainage from the ureteropelvic junction to ... for ease of placement and patient compliance. ... for repositioning and ease of removal. AQ® ... that when activated, attracts and holds water ...
... a PC-based ECG device that can ... and an innovative software. The system ... recording using a standard 12-lead setup ... The software includes two applications: Rest ...
Medicine Products: